Another study indicated that CDC6 was involved in the replication licensing and the proliferation, migration, and invasion of lung cancer cells mediated by miR-26a and miR-26b, and CDC6 represented potential cancer diagnostic and prognostic markers as well as anticancer targets [45]. The gene discussed is CDC6; the disease is cancer.